DDX53 and neoplasm: CT26 tumour-bearing mice were treated with LC4 (4 mg/kg/day), LC4-PLG-RGD or RGD-PLG-LC4 (6.2 mg/kg/day) by injected in tail vein for 14 days (Fig. 7A–D).